Dose optimisation of intravenous tranexamic acid for elective hip and knee arthroplasty: The effectiveness of a single pre-operative dose

OBJECTIVES: We have increased the dose of tranexamic acid (TXA) in our enhanced total joint recovery protocol at our institution from 15 mg/kg to 30 mg/kg (maximum 2.5 g) as a single, intravenous (IV) dose. We report the clinical effect of this dosage change. METHODS: We retrospectively compared two...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone Joint Res
Main Authors: Morrison, R. J. M., Tsang, B., Fishley, W., Harper, I., Joseph, J. C., Reed, M. R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5579309/
https://ncbi.nlm.nih.gov/pubmed/28851694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1302/2046-3758.68.BJR-2017-0005.R1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados